Development of the Database for Look-Alike, Sound-Alike Drugs in Thailand
Article Sidebar
Main Article Content
Abstract
Objective: To develop the database on look-alike, sound-alike (LASA) drugs in Thailand as a searchable resource for hospitals. Method: The researchers developed the database based on six steps of the System Development Life Cycle including preliminary investigation, systems analysis, systems design, systems development, system implementation and evaluation, and evaluation of satisfaction among users. Satisfaction in the use of database was assessed in 85 hospital pharmacists selected by convenient sampling and snowball sampling. Results: The developed LASA drug database established four levels of clinical significance of LASA drugs based on their severity. The database contained 193 LASA tablets and capsules. LASA drugs were classified into three types including look-alike names or sounds or written names, look-alike packaging and look-alike physical appearances of pills. Those with look-alike names or sounds or written names were the most commonly reported. Database users were very satisfied with the design and the search and display aspects. They were most satisfied in terms of application. Conclusion: Thai LASA drugs database developed by Faculty of Pharmacy, Ubon Ratchathani University is the first one to compile LASA drugs systematically. The LASA drugs can be searched by generic names, trade names, level of clinical significance of LASA drugs and the degree of severity of medication errors. This database can be used as a searchable reference as well as being a tool for surveillance and prevention of the potential problems on LASA drugs both at the hospital and national levels.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ผลการวิจัยและความคิดเห็นที่ปรากฏในบทความถือเป็นความคิดเห็นและอยู่ในความรับผิดชอบของผู้นิพนธ์ มิใช่ความเห็นหรือความรับผิดชอบของกองบรรณาธิการ หรือคณะเภสัชศาสตร์ มหาวิทยาลัยสงขลานครินทร์ ทั้งนี้ไม่รวมความผิดพลาดอันเกิดจากการพิมพ์ บทความที่ได้รับการเผยแพร่โดยวารสารเภสัชกรรมไทยถือเป็นสิทธิ์ของวารสารฯ
References
Ciccarello C, Leber MB, Leonard MC, Nesbit T, Petrovskis MG, Pherson E, et al. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. Am J Health Syst Pharm 2021; 78: 907-18.
Association of Hospital Pharmacist (Thailand). Framework of hospital drug system [online]. 2020 [cited Aug 6, 2022]. Available from: www.thaihp.org /?fbclid=IwAR1itl_pQ0hVUnrJEyNBzfI_OBKIvUbos2QeTzhVQBtG1KDFGnaZxFtJN0U
Joint Commission on Accreditation of Healthcare Organizations (JCAHO). JCAHO update for infection control: 2005 patient safety goals warn of sound-alike drugs [online]. 2005 [cited Oct 11, 2022]. Available from: www.reliasmedia.com/articles/3258-jcaho-update-for-infection-control-2005-patient-safety-goals-warn-of-sound-alike-drugs
World Health Organization. WHO launches 'Nine patient safety solutions' [online]. 2007 [cited Aug 12, 2022]. Available from: www.who.int/news/item/02-05-2007-who-launches-nine-patient-safety-solutions
Limpanyalert P. 2P Safety patient and personnel safety [online]. 2017 [cited Jan 2, 2022]. Available from: hacc.kku.ac.th/haccupload_news/pdftitle/Tue2 4545uFpjMOP.pdf
Emmerton LM, Rizk MF. Look-alike and sound-alike medicines: risks and 'solutions'. Int J Clin Pharm 2012; 34: 4-8.
Institute for Safe Medication Practices (ISMP). ISMP list of confused drug names [online]. 2019 [cited Oct 11, 2022]. Available from: www.ismp.org/recommen dations/confused-drug-names-list
Bryan R, Aronson JK, Williams AJ, Jordan S. A systematic literature review of LASA error interven- tions. Br J Clin Pharmacol 2021; 87: 336-51.
Chumchit C, Amrumpai Y, Treesak C. Recognition on medication safety and look-alike/sound-alike medication problems in Thai public hospitals. Science, Engineering and Health Studies 2015: 9: 40-51.
Chanakit T, Napaporn J, Chiempattanakajohn T, Sangkhawan S, Wichakot S. The survey of look alike /sound alike (LASA) drugs available in hospitals in Thailand. Afr J Pharm Pharmacol 2013; 7: 227-39.
de Vicente Mohino J, Bermejo Higuera J, Bermejo Higuera JR, Sicilia Montalvo JA. The application of a new secure software development life cycle (S-SDLC) with agile methodologies. Electronics 2019; 8: 1218.
Joseph AL, Stringer E, Borycki EM, Kushniruk AW. Evaluative frameworks and models for health information systems (HIS) and health information technologies (HIT). Stud Health Technol Inform 2022; 289: 280-5.
Phunaploy N, Chatwattana P. The concept of an intelligent database management system architec- ture on cloud to support the inventory storage. Journal of Industrial Education 2020; 19: 111-21.
Promsaka Na Sakolnakorn T, Sungkharat U, Tep- sing P. Problems and adjustments of convenience store entrepreneurs in three Southern border provinces in Thailand. NIDA Development Journal 2013; 53: 82-103.
National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). Types of medication errors [online]. 2022 [cited Oct 11, 2022]. Available from: www.nccmerp.org/types-medication-errors
Wongboonnak P. Look-alike sound-alike drugs situation in Thailand. HCU Journal of Health Science 2018; 22: 205-16.
Wongboonnak P. Resolving the problems on look-alike sound-alike drugs at the system level. Thai Journal of Pharmacy Practice 2017; 9: 251-8.
Faculty of Pharmaceutical Sciences URU. Drug iden tification database [online]. 2022 [cited Oct 11, 2022]. Available from: drugiden.ubu.ac.th/
Santell JP, Hicks RW, McMeekin J, Cousins DD. Medication errors: experience of the United States Pharmacopeia (USP) MEDMARX reporting system. J Clin Pharmacol 2003; 43: 760-7.
World Health Organization. Guidance on INN [on line]. 1997 [cited Dec 24, 2021]. Available from: www .who.int/medicines/services/inn/innquidance/en/
